0.0066USD-5.71%Mkt Cap: 874698 USDP/E: —Last update: 2026-05-26
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a ho…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap874.70K USD
Enterprise Value—
Revenue (TTM)—
Gross Profit15.57M USD
Net Income (TTM)391.00K USD
Revenue/Share0.1630 USD
Last Price0.0066 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30048L2034
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.01
EPS (TTM)-0.05
EPS (Forward)-0.55
52W Range
0.001029% of range0.0200
52W High0.0200 USD
52W Low0.0010 USD
Profitability
Gross Margin77.12%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin1.94%
ROE-0.53%
ROA1.93%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.99M USD
CapEx (TTM)5.00K USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.73
Current Ratio—
Quick Ratio—
Book Value/Sh-0.5870 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2018
Splits
Last Split1:125
Split DateMay 18, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.132.53M
Float—
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float11.01%
Short % Out.10.98%
Shares Short69.46K
Short (prev mo.)142.57K
Technical
SMA 500.0081 (-18.9%)
SMA 2000.0097 (-32.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)288.39K
Avg Vol (10d)114.02K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—